Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. [electronic resource]
Producer: 20200710Description: 101647 p. digitalISSN:- 1873-0442
- Adenosine Monophosphate -- analogs & derivatives
- Alanine -- analogs & derivatives
- Angiotensin-Converting Enzyme 2
- Antiviral Agents -- chemistry
- Betacoronavirus -- chemistry
- COVID-19
- Clinical Trials as Topic
- Coronavirus Infections -- drug therapy
- Genome, Viral -- genetics
- Humans
- Pandemics
- Peptidyl-Dipeptidase A -- chemistry
- Pneumonia, Viral -- drug therapy
- SARS-CoV-2
- Spike Glycoprotein, Coronavirus -- chemistry
- COVID-19 Drug Treatment
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.